Home › Colorectal Cancer › Texas › Round Rock
Colorectal Cancer clinical trials in Round Rock, TX
3 studies for Colorectal Cancer are looking for participants at sites in and around Round Rock (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RecruitingPhase 1
- Research Site, Round Rock
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
RecruitingPhase 3
- Baylor Scott & White Medical Center, Round Rock
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
RecruitingPhase 3
- Baylor Scott and White Health 1, Round Rock
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX102 studies
- New York City, NY77 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA38 studies
- Seattle, WA34 studies
Other studies in Round Rock
- Parkinson's Disease9 studies
- Ulcerative Colitis8 studies
- Crohn's Disease7 studies
- Steatotic Liver Disease7 studies
- Inflammatory Bowel Disease5 studies
- Non-Small Cell Lung Cancer4 studies
- Alzheimer's Disease4 studies
- Obesity4 studies
- Type 2 Diabetes4 studies
- Mild Cognitive Impairment3 studies
- Liver Diseases3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.